Medical Isotope Pitch Sheet

1
MEDICAL ISOTOPES A Pathway to Prosperity Volume 1 Issue 3 www.eGeneration.org MEDICAL ISOTOPE PRODUCTION What You Should Know: America has no significant domestic supply of Molybdenum99, a very important medical isotope used in 320,000 procedures in the U.S. per week. Molybdenum99 allows medical science to peer inside the body without exploratory surgery. This greatly reduces medical costs and allows for a quicker and a better diagnosis of patients. America imports Molybdenum99 from two reactors, one in Canada and one in the Netherlands. Both are nearing the end of their useful life. We have already had supply disruptions of Molybdenum99 since 2010 due to reactor maintenance and breakdown issues overseas. The current strategy of the United States is to produce Molybdenum99 from LowEnriched Uranium (LEU), which is very inefficient compared to producing Molybdenum99 from Highly Enriched Uranium (HEU) HEU is a proliferation risk because it can be used to make nuclear weapons. Molten Salt Reactors do not produce HEU Molten Salt Reactors can produce Molybdenum99 during their normal course of operation, and do so hundreds of times more efficiently than current HEU and LEU processes. Molten Salt Reactors can also produce very rare isotopes such as Actinium 225 that are vital in research and treatment of the most egregious forms of cancer. The eGeneration Foundation is working to form an alliance to develop a national energy plan, promoting the next generation of fuels powered by Molten Salt Reactor technology. As studies and analysis of this promising technology become widely understood, there will be widespread industry support for commercializing this next generation process, thus providing a clear pathway to American economic prosperity. 1768 East 25 th Street Suite 301 Cleveland, OH 44114 216.367.0602 www.eGeneration.org The eGeneration Foundation is a 501(c)3 nonprofit educational charity. Your contribution to the eGeneration Foundation is taxdeductible as a charitable contribution to the extent allowed by law. Please consider making a generous donation and join our efforts to help create an energy rich future for all. Copyright © 2015 by eGeneration Foundation All rights reserved

description

 

Transcript of Medical Isotope Pitch Sheet

Page 1: Medical Isotope Pitch Sheet

 

 

MEDICAL ISOTOPES A  Pathway  to  Prosperity  

Volume  1  Issue  3  

                                                                       

 www.eGeneration.org

MEDICAL ISOTOPE PRODUCTION What  You  Should  Know:  

• America  has  no  significant  domestic  supply  of  Molybdenum-­‐99,  a  very  important  medical  isotope  used  in  320,000  procedures  in  the  U.S.  per  week.  

• Molybdenum-­‐99  allows  medical  science  to  peer  inside  the  body  without  exploratory  surgery.  This  greatly  reduces  medical  costs  and  allows  for  a  quicker  and  a  better  diagnosis  of  patients.  

• America  imports  Molybdenum-­‐99  from  two  reactors,  one  in  Canada  and  one  in  the  Netherlands.  Both  are  nearing  the  end  of  their  useful  life.    

• We  have  already  had  supply  disruptions  of  Molybdenum-­‐99  since  2010  due  to  reactor  maintenance  and  breakdown  issues  overseas.  

• The  current  strategy  of  the  United  States  is  to  produce  Molybdenum-­‐99  from  Low-­‐Enriched  Uranium  (LEU),  which  is  very  inefficient  compared  to  producing  Molybdenum-­‐99  from  Highly  Enriched  Uranium  (HEU)    

• HEU  is  a  proliferation  risk  because  it  can  be  used  to  make  nuclear  weapons.  • Molten  Salt  Reactors  do  not  produce  HEU  • Molten  Salt  Reactors  can  produce  Molybdenum-­‐99  during  their  normal  course  of  operation,  and  do  so  hundreds  of  times  more  efficiently  than  current  HEU  and  LEU  processes.  

• Molten  Salt  Reactors  can  also  produce  very  rare  isotopes  such  as  Actinium-­‐225  that  are  vital  in  research  and  treatment  of  the  most  egregious  forms  of  cancer.  

The  eGeneration  Foundation  is  working  to  form  an  alliance  to  develop  a  national  energy  plan,  promoting  the  next  generation  of  fuels  powered  by  Molten  Salt  Reactor  technology.    As  studies  and  analysis  of  this  promising  technology  become  widely  understood,  there  will  be  widespread  industry  support  for  commercializing  this  next  generation  process,  thus  providing  a  clear  pathway  to  American  economic  prosperity.  

1768  East  25th  Street  Suite  301  

Cleveland,  OH  44114  216.367.0602  

www.eGeneration.org  

 The  eGeneration  Foundation  is  a  

501(c)3  non-­‐profit  educational  charity.  

Your  contribution  to  the  eGeneration  Foundation  is  

tax-­‐deductible  as  a  charitable  contribution  to  the  extent  allowed  by  law.  

 Please  consider  

making  a  generous  donation  and  join  our  efforts  to  help  create  an  energy  rich  future  for  all.    

Copyright  ©  2015  by  eGeneration  Foundation  All  rights  reserved